HER2 dimerization inhibitor pertuzumab: mode of action and clinical data in breast cancer
The humanized monoclonal antibody pertuzumab prevents the dimerization of HER2 with other HER receptors, in particular the pairing of the most potent signaling heterodimer HER2/HER3, thus providing a potent strategy for dual HER2 inhibition. It binds to the extracellular domain of HER2 at a differen...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
February 18, 2013
|
| In: |
Breast care
Year: 2013, Volume: 8, Issue: 1, Pages: 49-55 |
| ISSN: | 1661-3805 |
| DOI: | 10.1159/000346837 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1159/000346837 Verlag, lizenzpflichtig, Volltext: https://www.karger.com/Article/FullText/346837 
|
| Author Notes: | Nadia Harbeck, Matthias W. Beckmann, Achim Rody, Andreas Schneeweiss, Volkmar Müller, Tanja Fehm, Norbert Marschner, Oleg Gluz, Iris Schrader, Georg Heinrich, Michael Untch, Christian Jackisch |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1749400561 | ||
| 003 | DE-627 | ||
| 005 | 20220819121133.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210225s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1159/000346837 |2 doi | |
| 035 | |a (DE-627)1749400561 | ||
| 035 | |a (DE-599)KXP1749400561 | ||
| 035 | |a (OCoLC)1341395746 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Harbeck, Nadia |e VerfasserIn |0 (DE-588)113605633 |0 (DE-627)511270666 |0 (DE-576)172888581 |4 aut | |
| 245 | 1 | 0 | |a HER2 dimerization inhibitor pertuzumab |b mode of action and clinical data in breast cancer |c Nadia Harbeck, Matthias W. Beckmann, Achim Rody, Andreas Schneeweiss, Volkmar Müller, Tanja Fehm, Norbert Marschner, Oleg Gluz, Iris Schrader, Georg Heinrich, Michael Untch, Christian Jackisch |
| 246 | 3 | 0 | |a two |
| 264 | 1 | |c February 18, 2013 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 26.02.2021 | ||
| 520 | |a The humanized monoclonal antibody pertuzumab prevents the dimerization of HER2 with other HER receptors, in particular the pairing of the most potent signaling heterodimer HER2/HER3, thus providing a potent strategy for dual HER2 inhibition. It binds to the extracellular domain of HER2 at a different epitope than trastuzumab. Pertuzumab and trastuzumab act in a complementary fashion and provide a more complete blockade of HER2-mediated signal transduction than either agent alone. Phase II studies demonstrated that pertuzumab was generally well tolerated as a single agent or in combination with trastuzumab and/or cytotoxic agents, and implied an improved clinical efficacy of the combination of pertuzumab and trastuzumab in early and advanced HER2-positive breast cancer. Results of the pivotal phase III study CLEOPATRA in patients with HER2-positive metastatic breast cancer demonstrated that the addition of pertuzumab to first-line combination therapy with docetaxel and trastuzumab significantly prolonged progression-free and overall survival without increasing cardiac toxicity. Currently, the combination of both antibodies is being explored in the palliative setting as well as in the treatment of early HER2-positive breast cancer. Dual HER2 inhibition with the HER2 dimerization inhibitor pertuzumab and trastuzumab may change clinical practice in HER2-positive first-line metastatic breast cancer treatment. | ||
| 700 | 1 | |a Schneeweiss, Andreas |d 1961- |e VerfasserIn |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Breast care |d Basel : Karger, 2006 |g 8(2013), 1, Seite 49-55 |h Online-Ressource |w (DE-627)501078142 |w (DE-600)2205941-6 |w (DE-576)276272617 |x 1661-3805 |7 nnas |a HER2 dimerization inhibitor pertuzumab mode of action and clinical data in breast cancer |
| 773 | 1 | 8 | |g volume:8 |g year:2013 |g number:1 |g pages:49-55 |g extent:7 |a HER2 dimerization inhibitor pertuzumab mode of action and clinical data in breast cancer |
| 856 | 4 | 0 | |u https://doi.org/10.1159/000346837 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.karger.com/Article/FullText/346837 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210225 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 109972554 |a Schneeweiss, Andreas |m 109972554:Schneeweiss, Andreas |d 910000 |d 910400 |e 910000PS109972554 |e 910400PS109972554 |k 0/910000/ |k 1/910000/910400/ |p 4 | ||
| 999 | |a KXP-PPN1749400561 |e 3874302431 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"HER2 dimerization inhibitor pertuzumab","title":"HER2 dimerization inhibitor pertuzumab","subtitle":"mode of action and clinical data in breast cancer"}],"id":{"eki":["1749400561"],"doi":["10.1159/000346837"]},"physDesc":[{"extent":"7 S."}],"relHost":[{"note":["Gesehen am 04.04.2019"],"pubHistory":["1.2006 -"],"part":{"year":"2013","volume":"8","text":"8(2013), 1, Seite 49-55","pages":"49-55","extent":"7","issue":"1"},"language":["eng"],"disp":"HER2 dimerization inhibitor pertuzumab mode of action and clinical data in breast cancerBreast care","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"501078142","origin":[{"dateIssuedKey":"2006","publisherPlace":"Basel","publisher":"Karger","dateIssuedDisp":"2006-"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["501078142"],"issn":["1661-3805"],"zdb":["2205941-6"]},"title":[{"title_sort":"Breast care","title":"Breast care","subtitle":"multidisciplinary journal for research, diagnosis and therapy"}]}],"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"February 18, 2013"}],"language":["eng"],"name":{"displayForm":["Nadia Harbeck, Matthias W. Beckmann, Achim Rody, Andreas Schneeweiss, Volkmar Müller, Tanja Fehm, Norbert Marschner, Oleg Gluz, Iris Schrader, Georg Heinrich, Michael Untch, Christian Jackisch"]},"recId":"1749400561","person":[{"role":"aut","family":"Harbeck","display":"Harbeck, Nadia","given":"Nadia"},{"given":"Andreas","display":"Schneeweiss, Andreas","family":"Schneeweiss","role":"aut"}],"note":["Gesehen am 26.02.2021"]} | ||
| SRT | |a HARBECKNADHER2DIMERI1820 | ||